TY - JOUR
T1 - A typical Y1 receptor regulates feeding behaviors
T2 - Effects of a potent and selective Y1 antagonist, J-115814
AU - Kanatani, Akio
AU - Hata, Mikiko
AU - Mashiko, Satoshi
AU - Ishihara, Akane
AU - Okamoto, Osamu
AU - Haga, Yuji
AU - Ohe, Tomoyuki
AU - Kanno, Tetsuya
AU - Murai, Naomi
AU - Ishii, Yasuyuki
AU - Fukuroda, Takahiro
AU - Fukami, Takehiro
AU - Ihara, Masaki
PY - 2001
Y1 - 2001
N2 - Neuropeptide Y (NPY) is a potent feeding stimulant. The orexigenic effect of NPY might be caused in part by the action of Y1 receptors. However, the existence of multiple NPY receptors including a possible novel feeding receptor has made it difficult to determine the relative importance of the Y1 receptor in feeding regulation. Herein we certified that the Y1 receptor is a major feeding receptor of NPY by using the potent and selective Y1 antagonist (-)-2-[1-(3-chloro-5isopropyloxycarbon-ylaminophenyl)ethylamino]-6-[2-(5-ethy l-4-methyl-1,3-thiazol-2-yl)ethyl]-4-morpholinopyridine (J-115814) and Y1 receptordeficient (Y1-/-) mice. J-115814 displaced 125l-peptide YY binding to cell membranes expressing cloned human, rat, and murine Y1 receptors with Ki values of 1.4, 1.8, and 1.9 nM, respectively, and inhibited NPY (10 nM)-induced increases in intracellular calcium levels via human Y1 receptors (IC50 = 6.8 nM). In contrast, J-115814 showed low affinities for human Y2 (Ki > 10 μM), Y4 (Ki = 640 nM) and Y5 receptors (Ki = 6000 nM). Intracerebroventricular (ICV) (10-100 μg) and intravenous (IV) (0.3-30 mg/kg) administration of J-115814 significantly and dose-dependently suppressed feeding induced by ICV NPY (5 μg) in satiated Sprague-Dawley rats. Intraperitoneal (IP) administration of J-115814 (3-30 mg/kg) significantly attenuated spontaneous feeding in db/db and C57BL6 mice. Feeding induced by ICV NPY (5 μg) was unaffected by IP-injected J-115814 (30 mg/kg) in Y1-/- mice and was suppressed in wild-type and Y5-/- mice. These findings clearly suggest that J-115814 inhibits feeding behaviors through the inhibition of the typical Y1 receptor. We conclude that the Y1 receptor plays a key role in regulating food intake.
AB - Neuropeptide Y (NPY) is a potent feeding stimulant. The orexigenic effect of NPY might be caused in part by the action of Y1 receptors. However, the existence of multiple NPY receptors including a possible novel feeding receptor has made it difficult to determine the relative importance of the Y1 receptor in feeding regulation. Herein we certified that the Y1 receptor is a major feeding receptor of NPY by using the potent and selective Y1 antagonist (-)-2-[1-(3-chloro-5isopropyloxycarbon-ylaminophenyl)ethylamino]-6-[2-(5-ethy l-4-methyl-1,3-thiazol-2-yl)ethyl]-4-morpholinopyridine (J-115814) and Y1 receptordeficient (Y1-/-) mice. J-115814 displaced 125l-peptide YY binding to cell membranes expressing cloned human, rat, and murine Y1 receptors with Ki values of 1.4, 1.8, and 1.9 nM, respectively, and inhibited NPY (10 nM)-induced increases in intracellular calcium levels via human Y1 receptors (IC50 = 6.8 nM). In contrast, J-115814 showed low affinities for human Y2 (Ki > 10 μM), Y4 (Ki = 640 nM) and Y5 receptors (Ki = 6000 nM). Intracerebroventricular (ICV) (10-100 μg) and intravenous (IV) (0.3-30 mg/kg) administration of J-115814 significantly and dose-dependently suppressed feeding induced by ICV NPY (5 μg) in satiated Sprague-Dawley rats. Intraperitoneal (IP) administration of J-115814 (3-30 mg/kg) significantly attenuated spontaneous feeding in db/db and C57BL6 mice. Feeding induced by ICV NPY (5 μg) was unaffected by IP-injected J-115814 (30 mg/kg) in Y1-/- mice and was suppressed in wild-type and Y5-/- mice. These findings clearly suggest that J-115814 inhibits feeding behaviors through the inhibition of the typical Y1 receptor. We conclude that the Y1 receptor plays a key role in regulating food intake.
UR - http://www.scopus.com/inward/record.url?scp=0035125558&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035125558&partnerID=8YFLogxK
U2 - 10.1124/mol.59.3.501
DO - 10.1124/mol.59.3.501
M3 - Article
C2 - 11179445
AN - SCOPUS:0035125558
SN - 0026-895X
VL - 59
SP - 501
EP - 505
JO - Molecular Pharmacology
JF - Molecular Pharmacology
IS - 3
ER -